MARKET

LEXXW

LEXXW

Lexaria Bioscien
NASDAQ
0.5111
-0.2489
-32.75%
Opening 12:45 04/24 EDT
OPEN
0.7300
PREV CLOSE
0.7600
HIGH
0.7500
LOW
0.5111
VOLUME
4.61K
TURNOVER
0
52 WEEK HIGH
2.500
52 WEEK LOW
0.0500
MARKET CAP
--
P/E (TTM)
0.0000
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at LEXXW last week (0415-0419)?
Weekly Report · 2d ago
Lexaria Receives Ethics Review Board Approval To Begin New GLP-1 Study, Investigating GLP-1 Drugs And DehydraTECH
Human Pilot Study #2 (GLP-1-H24-2) Approved for human pilot study #2. Lexaria Bioscience Corp. Is a global innovator in drug delivery platforms. Study will investigate oral delivery of GLp-1 drugs and DehydraTECH. The Company anticipates completing the Study this summer.
Benzinga · 04/16 13:17
Weekly Report: what happened at LEXXW last week (0408-0412)?
Weekly Report · 04/15 10:53
Lexaria Bioscience Corp. Quarterly Report on Form 10-Q for the Quarterly Period Ended February 29, 2024
Press release · 04/09 21:04
Weekly Report: what happened at LEXXW last week (0401-0405)?
Weekly Report · 04/08 10:58
Weekly Report: what happened at LEXXW last week (0325-0329)?
Weekly Report · 04/01 10:56
Weekly Report: what happened at LEXXW last week (0318-0322)?
Weekly Report · 03/25 10:58
Weekly Report: what happened at LEXXW last week (0311-0315)?
Weekly Report · 03/18 10:57
More

Webull offers Lexaria Bioscience Corp stock information, including NASDAQ: LEXXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXXW stock methods without spending real money on the virtual paper trading platform.